472 related articles for article (PubMed ID: 25989948)
21. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
Reinemann C; Strehlitz B
Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
[TBL] [Abstract][Full Text] [Related]
22. Aptamer-functionalized liposomes for targeted cancer therapy.
Moosavian SA; Sahebkar A
Cancer Lett; 2019 Apr; 448():144-154. PubMed ID: 30763718
[TBL] [Abstract][Full Text] [Related]
23. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
24. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
[TBL] [Abstract][Full Text] [Related]
25. Recent trends in cancer drug resistance reversal strategies using nanoparticles.
Palakurthi S; Yellepeddi VK; Vangara KK
Expert Opin Drug Deliv; 2012 Mar; 9(3):287-301. PubMed ID: 22339554
[TBL] [Abstract][Full Text] [Related]
26. RNA Aptamer-functionalized Polymeric Nanoparticles in Targeted Delivery and Cancer Therapy: An up-to-date Review.
Marangoni K; Menezes R
Curr Pharm Des; 2022; 28(34):2785-2794. PubMed ID: 36056830
[TBL] [Abstract][Full Text] [Related]
27. Targeted Theranostics Against Solid Cancer Using Metal Bond Milk Protein and Aptamers.
Chaudhary S; Kanwar RK; Kanwar JR
Curr Top Med Chem; 2017 Jun; 17(18):2100-2111. PubMed ID: 28137239
[TBL] [Abstract][Full Text] [Related]
28. Aptamer Functionalized Cisplatin-Albumin Nanoparticles for Targeted Delivery to Epidermal Growth Factor Receptor Positive Cervical Cancer.
Chen Y; Wang J; Wang J; Wang L; Tan X; Tu K; Tong X; Qi L
J Biomed Nanotechnol; 2016 Apr; 12(4):656-66. PubMed ID: 27301192
[TBL] [Abstract][Full Text] [Related]
29. Challenging cancer targets for aptamer delivery.
de Franciscis V
Biochimie; 2018 Feb; 145():45-52. PubMed ID: 28962871
[TBL] [Abstract][Full Text] [Related]
30. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
[TBL] [Abstract][Full Text] [Related]
31. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
[TBL] [Abstract][Full Text] [Related]
32. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics.
Sheikh A; Md S; Alhakamy NA; Kesharwani P
Int J Pharm; 2022 May; 620():121751. PubMed ID: 35436511
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic aptamers: developmental potential as anticancer drugs.
Lee JW; Kim HJ; Heo K
BMB Rep; 2015 Apr; 48(4):234-7. PubMed ID: 25560701
[TBL] [Abstract][Full Text] [Related]
34. Aptamer as a targeted approach towards treatment of breast cancer.
Bisht A; Bhowmik S; Patel P; Gupta GD; Kurmi BD
J Drug Target; 2024 Jun; 32(5):510-528. PubMed ID: 38512151
[TBL] [Abstract][Full Text] [Related]
35. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
[TBL] [Abstract][Full Text] [Related]
37. Advances of aptamer-based clinical applications for the diagnosis and therapy of cancer.
Zhong Y; Wu P; He J; Zhong L; Zhao Y
Discov Med; 2020; 29(158):169-180. PubMed ID: 33007192
[TBL] [Abstract][Full Text] [Related]
38. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
39. Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents.
Wang Z; Xia J; Cai F; Zhang F; Yang M; Bi S; Gui R; Li Y; Xia Y
Colloids Surf B Biointerfaces; 2015 Oct; 134():40-6. PubMed ID: 26142627
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
